USPTO Covid-19 Relief Effort Grants Nearly 400 Applications Prioritized Status

As part of the U.S. Federal Government’s response to Covid-19, the USPTO announced programs to prioritize Covid-19 related patent and trademark applications this past May and June respectively. Since this summer, applicants were permitted to apply for special status without the normal payment requirements for special status.

Thus far, the USPTO has ushered in nearly 400 such applications with 251 patent requests and 133 trademark petitions granted. Of the patent applications, most target medical treatments, vaccines, and diagnostic technology. The remaining make claims on ventilators, personal protective equipment (PPE), and other similar technology.  The program has resulted in 33 granted patents already related to combatting Covid-19.

“Our staff is working very hard to move COVID-19 related patent and trademark requests, ensuring the intellectual property system is fully responsive to this national emergency,” said Andrei Iancu, Under Secretary of Commerce for Intellectual Property and Director of the USPTO. “Over the past two centuries, solutions to some of the nation’s greatest problems have passed through the halls of the USPTO, and it’s very likely that some of the solutions to America’s current pandemic have already been examined by this agency.”

The success of these programs reflects the monumental efforts made by the USPTO in its Covid-19 response, as we’ve covered throughout.

Maier & Maier has embraced these programs to assist our clients and help combat the ongoing virus. If you have any questions or concerns about the pilot or how it may apply to your applications, please reach out to us here.


Kunin: Arthrex & Click-To-Call Highlight Patent Law Cases in 2020

As 2020 comes to a close, leading IP experts are taking stock of the year that was and its effect on U.S. patent law. Among these expert opinions is Maier & Maier’s own Steve Kunin, who commented on two of the most significant patent cases this year in Arthrex, Inc. v. Smith & Nephew, Inc. and Thryv v. Click-to-Call.

Thryv v. Click-to-Call, 140 S. Ct. 1367 (April 20, 2020)

“The Supreme Court held that a PTAB determination of whether an IPR petition is timely under 35 U.S.C. § 315(b) cannot be judicially reviewed. The Court, in the majority opinion by Justice Ginsburg, held that § 315(b) time bar determinations are not appealable, vacated, and remanded with instructions for the Federal Circuit to dismiss for lack of jurisdiction. This decision reinforced the Congressional intent to provide the USPTO with broad discretion in making AIA trial institution decisions.”

Arthrex, Inc. v. Smith & Nephew, Inc., 941 F.3d 1320 (Fed. Cir. 2019), reh’g denied, 953 F.3d 760 (March 23, 2020

“The Federal Circuit held that USPTO APJs were unconstitutionally appointed under the Appointments Clause. The judges are not “inferior officers” and should have been appointed by the President and confirmed by the Senate. The Court then “fixed” the problem by stripping out the civil servant protections set forth in 5 U.S.C. that prevented the judges from being fired without cause. The case is now before the Supreme Court on certiorari. If the Federal Circuit’s decision is not reversed it will require Congress to enact legislation to correct the problem. The U.S. Government’s position is predicated on the finding that APJs are inferior officers that have been duly appointed.”

As Arthrex is pending before the Supreme court, it may be one of the most influential in 2021 as well. For more commentary on the year in review, see the full article here.


Kunin Thankful for Strong USPTO Leadership In 2020

This Thanksgiving, Maier & Maier’s Steve Kunin noted the strength of USPTO leadership as Director Iancu deftly handled the ongoing pandemic to keep the office productive and effective.

“We should continue to be grateful for Director Andrei Iancu’s leadership and stewardship of the USPTO during these trying times caused by the adverse impacts of COVID-19. With his strong leadership, the USPTO has continued to provide vital services to the patent and trademark user communities.”

Kunin specifically noted the Iancu’s adjustments at the USPTO and responses to pandemic challenges as covered here.

“His outreach efforts have been well received and the USPTO has been open-minded and responsive to public feedback on how it can make continuous quality improvements to its services and products.”

As Kunin notes, this leadership would have been lost if not for the dedication of the USPTO employees as a whole who were forced to adjust to extensive telework like many other industries.

“Kudos as well to all the USPTO employees who have had to adapt to more extensive telework while striving to maintain continuity of operations.”

For more thoughts on the year in IP and appreciation from other experts and practitioners, see the full piece here.


Maier & Maier Named As Best Firm By U.S. News and World Report and Best Lawyers Magazine

U.S. News & World Report and Best Lawyers magazine has named it’s 2021 Best Law Firms, and named Maier & Maier among the best in the field.

Maier & Maier was named for its excellence in patent law in Washington, D.C. The firm prides itself on providing the highest possible service to each of its clients with a reknowned expertise for patents and intellectual property as a whole. The recognition comes after years of continued growth and success since its founding in 2006 by brothers, Tim and Chris Maier. The two have practiced for decades both at the USPTO as examiners and in private practice, giving them each unmatched expertise in the field.

The firm firm’s success comes in all facets of patent practice, with noted achievements in prosecution, litigation, and portfolio management. The firm successfully earns over a thousand granted patents for its varied and valued clients each year and prides itself on its corporate friendly and streamlined reporting systems. In the past year, the firm has been heavily involved in PTAB matters, both for petitioners and patent owners.  The firm successfully defended multiple patents from IPR petitions and challenged competitor patents for their clients.

This recognition for the firm comes after both Tim & Chris were recognized by IAM Patent 1000 as some of the most successful IP attorneys in the world, along with fellow Maier & Maier partner, Steven Kunin.


IP Check-In On The Supreme Court Docket

There are currently multiple significant IP cases pending at the Supreme Court, including both the Oracle case and the Arthrex cases, and a number of petitions denied cert. Here are the latest case updates on IP at the Supreme Court:

Google v. Oracle

On October 7th, the Supreme Court heard oral arguments for the Google v. Oracle case on appeal from the Federal Circuit. The case centers around the Android operating system designed by Google in their first foray into the smartphone arena. In the coding, Google used 11,000 lines of the Java SE platform coding for common interface commands. Oracle, the current owner of the Java SE platform, filed suit on the basis that the use of the lines constituted infringement. While a jury found them to be “fair use”, the Federal Circuit disagreed, reversing the decision, and leading to the current appeal at the Supreme Court.

Accordingly, the questions before the Supreme Court now are:

(1) Whether copyright protection extends to a software interface; and

(2) whether, as the jury found, the petitioner’s use of a software interface in the context of creating a new computer program constitutes fair use.

The decision could be the most significant copyright decision in at least a decade and will be important to developers and practitioners alike to watch moving forward.

Arthrex

Earlier this month, the Supreme Court denied certiorari to a number of cases. Notably this does not include the Arthrex cases challenging the constitutionality of the USPTO’s Patent Trial & Appeal Board.

On October 14,, 2020, as predicted by Maier & Maier’s own, Steve Kunin, the Supreme Court granted cert in three related Arthex cases: (1) United States v. Arthrex, Inc. (19-1434), (2) Smith & Nephew, Inc. v. Arthrex, Inc. (19-1452), and (3) Arthrex, Inc. v. Smith & Nephew, Inc. (19-1458).

The case rests on the question of whether the Administrative Patent Judges (“APJ’s”) are principal officers or inferior officiers, and accordingly, whether their appointment is constitutional. Specifically, the Supreme Court has identified the following two questions for review:

(1) Whether, for purposes of the Appointments Clause, U.S. Const. Art. II, § 2, Cl. 2, administrative patent judges of the U.S. Patent and Trademark Office are principal officers who must be appointed by the President with the Senate’s advice and consent, or ‘inferior Officers’ whose appointment Congress has permissibly vested in a department head.

(2) Whether, if administrative patent judges are principal officers, the court of appeals properly cured any Appointments Clause defect in the current statutory scheme prospectively by severing the application of 5 U.S.C. 7513(a) to those judges.

Briefing and oral arguments, as well as likely amicus briefs will likely follow before these questions are resolved, and may be one of the first cases heard by any replacement for the late Ruth Bader Ginsburg on the Court.

Cert Denied

Unlike the pending Oracle and Arthrex decisions, the following cases have been denied certiorari by the Supreme Court and will not be heard on appeal:

      • BioDelivery Sciences International, Inc. v. Aquestive Therapeutics, Inc., fka MonoSol RX, LLC, No. 19-1381 (Appealing IPR Termination)
      • TCL Communication Technology Holdings Limited v. Telefonaktiebolaget LM Ericsson, No. 19-1269 (Right to a Jury Trial for Specific Performance of FRAND license)
      • Willowood, LLC v. Syngenta Crop Protection, LLC, No. 19-1147 (Divided Infringement and 271(g))
      • The Chamberlain Group, Inc. v. Techtronic Industries Co., No. 19-1299.; Thomas v. Iancu, No. 19-1435; Primbas v. Iancu, No. 19-1464; Morsa v. Iancu, No. 20-32 (Patent Eligibility)
      • Ameranth, Inc., Petitioner v. Domino’s Pizza, LLC, No. 19-1351 (Sua Sponte Judicial Order Due Process)
      • Polidi v. Lee, No. 19-1430; Piccone v. United States Patent and Trademark Office, No. 19-8844 (Exclusion of Patent Attorneys by USPTO)
      • SRAM, LLC v. FOX Factory, Inc., No. 20-158 (Secondary Indicia for Obviousness nexus)
      • Arthrex, Inc. v. Smith & Nephew, Inc., No. 19-1204 (Application of IPR decisions retroactively to related pending applications)
      • Cheetah Omni LLC v. AT&T Services, Inc., No. 20-68 (Licensing Patents under Federal & State law)

USPTO Well-Equipped For Surge Of Artificial Intelligence IP

As Artificial Intelligence (“AI”) continues to transform industries across both the U.S. and the globe, the United States Patent and Trademark Office has been handling the issues at a much higher rate. In response to the developing field, the USPTO released a report on AI and the related Intellectual Property issues.

“The USPTO has long been committed to ensuring our nation maintains its leadership in all areas of innovation, especially in emerging technologies such as artificial intelligence,” highlighted Andrei Iancu. Director of the USPTO. In preparing the report, the USPTO sought input from and received comments from over 200 comments from bar associations, trade associations, law firms, academic authorities, industry practitioners in electronics, software, automobiles, medical and pharmaceutical industries, and foreign patent offices.

Overall, the report indicates that there is a high degree of confidence in the USPTO to handle many of the issues relating to patent, trademark, and copyright issues relating to AI. The report also emphasized the importance of maintaining a close eye for the developments in this industry to ensure the U.S. maintains its status as a global leader in this critical technology.


Supreme Court Outlook: Nominee Amy Coney Barrett’s IP Record

With multiple IP issues percolating in the lower courts, there will likely be many federal issues decided in the coming years. With the passing of Justice Ginsberg, Amy Coney Barrett stands as the nominee to inherit those votes and a staunch textualist. Here are the some of the most recent Barrett decisions on intellectual property matters.

J.S.T. Corp. v. Foxconn Interconnect Technology (Trade Secrets)

This 7th Circuit appeal came earlier this year focusing on a trade secret misappropriation and jurisdiction to bring the claims. A customer to J.S.T. provided one of their proprietary adapter designs to J.S.T.’s competitor, Foxconn, attempting to have them manufacture them instead of J.S.T. J.S.T. filed suit in Illinois for misappropriation and unjust enrichment, but Foxconn moved to dismiss for lack of personal jurisdiction.

They argued that because Foxconn and the other defendants had no headquarters in Illinois and neither manufactured nor sold the adapters in Illinois, there could be no personal jurisdiction. Foxconn and the other defendants sold the adapters in Texas or China, which were bought to be used in automobiles which were then sold nationwide. J.S.T. argued that this downstream commerce in Illinois was sufficient to establish personal jurisdiction in trade secret cases, but the District Court disagreed.

On appeal, Judge Barrett authored the opinion, affirming the lower court. As Barrett explained “[f]or the point of consumer sale to be as relevant to this litigation as it is to products liability suits, there must also be a connection here between downstream consumer sales and J.S.T.’s underlying claims.” This differs from both product liability and trademark claims, which can satisfy jurisdiction requirements at the consumer level. For trade secrets, the claim bases of “acquisition, disclosure, and use of a secret are all actions that can be completed long before an offending product ever comes into contact with a consumer.” Accordingly, looking to the text of the trade secret claim language, Judge Barrett saw no basis for personal jurisdiction, and her peers agreed.

Ariel Investments, LLC v. Ariel Capital Advisors LLC (Trademark)

In 2018, the 7th Circuit heard a trademark dispute between the Florida-based Ariel Capital Advisors (ACA) and the Chicago-based Ariel Investments, LLC (AI). AI was founded in 1983, while ACA was formed in 2014, with each advising and managing financial investments. AI brought suit in 2018 for trademark infringement and sought an injunction requiring a name change by ACA in the District of Chicago. The court obliged with a court order, and ACA complied by changing their name to Bray Capital Advisors, but challenged the ruling on appeal.

ACA appealed on the basis that the court had no jurisdiction to decide the case, explaining that they had no office, no clients, no property, and no staff in Chicago, nor has any employee even visit Illinois at all. AI responded that for intellectual property cases, the defendant essentially “reached into the holder’s home forum to take its property” and availed itself to jurisdiction. The appellate court disagreed.

As Barrett explains in authoring the decision, “Perhaps the Lanham Act ought to authorize nationwide service, as the antitrust and securities laws do…[b]ut it does not, so personal jurisdiction depends on state law.” On that basis, AI failed to show specific jurisdiction or the requisite minimum contacts. As Barrett quotes from the Supreme Court decision in 2014, Walden v. Fiore, “the plaintiff cannot be the only link between the defendant and the forum. Rather, it is the defendant’s conduct that must form the necessary connection with the forum State that is the basis for its jurisdiction over him”. Accordingly, she explains “No matter how one might characterize the relation between Ariel Investments and Ariel Capital, it is easy to describe the relation between Illinois and Ariel Capital: none. That resolves this litigation.”

Sullivan v. Flora Inc. (Copyright)

In 2019, Barrett joined the majority decision siding the 7th Circuit with the 1st, 9th, 11th, and D.C. circuits in an ongoing split. In the case, the decision resolved the definition of “one work” and whether a compilation qualifies or is a set of different works. Amy Sullivan, a graphic design artist, produced 33 illustrations for Joseph Silver as part of his freelance product specialist work. The illustrations were for a project Silver was working on for Flora, Inc. Without Flora’s knowledge, Silver had used Sullivan for the project, and obtained excusive rights to the illustrations for two specific ad campaigns. Instead, Flora used the illustrations in the two campaigns, as well as a number of others.

Sullivan then registered 17 of the illustrations under one copyright and 16 under another, and filed suit against Flora, Inc. in the Western District of Wisconsin. Sullivan argued that each of the 33 illustrations was a part of “one work” and that she should be awarded statutory damages on each of the 33 counts. Conversely, Flora, Inc. argued that the statutory damages could only be awarded for each collective or group works, a mere 2 counts of infringement.

The district court found for Sullivan and awarded all 33 counts of statutory damages, but on appeal, the 7th Circuit reversed, with Barret joining the majority. As the decision explains, controlling weight should be afforded to the text of Section 504(c), providing that “all the parts of a compilation or derivative work constitute one work”, and to the artists decision to bundle the works or to issue them separately.

Unsurprisingly, Barrett’s minimal IP record shows a consistency with her larger approach to judicial analysis, with an emphasis on the statutory language and adherence thereto. Should she pass the senate, she would bolster an already statutorily inclined bench, providing IP owners with greater predictability on their rights moving forward.


Maier & Maier Secures Sale for Client After Successfully Prosecuting Portfolio of Patents

Maier & Maier has officially secured a deal for its clients on a patent portfolio in the gas-flow technology field.

Maier & Maier successfully prosecuted the patent portfolio on behalf of the inventor. With the demonstrated high quality of Maier & Maier’s drafting and prosecution, the inventions drew interest from the purchaser. Maier & Maier was able to efficiently and effectively coordinate the sale transferring the portfolio.

The transaction is the latest example of the high quality service Maier & Maier provides our clients in all IP matters.


USPTO Forms Council to Bolster Inventor Diversity Platform

Earlier this year, the USPTO launched the new Expanding Innovation Hub Platform. The Hub is designed to help foster inventorship from underrepresented groups including both female and minority inventors. As emphasized by USPTO Director Andrei Iancu, “To maintain our technological leadership, the United States must seek to broaden our intellectual property ecosystem demographically, geographically, and economically.”

The Hub includes an educational toolkit to help new inventors understand the system, mentoring programs to match inventors with individuals who can help them succeed in the system, and community groups to foster support and cooperation between inventors. The Hub will also serve as a base for events and programming focused on spurring innovation from the underrepresented groups.

Now, the USPTO has established the National Council for Expanding American Innovation (“NCEAI”). The Council is made up of 29 practitioners and Federal representatives and is tasked with building “a more diverse and inclusive innovation ecosystem” as emphasized by Director Iancu above. Part of the Council’s task will be period reporting such as the “Progress and Potential” report on female inventorship to hold the council accountable to the stated goals.

Per the Director of Commerce, Wilbur Ross, “It is critical that industry, academia, and government work together to strengthen our culture of innovation by encouraging the participation of young people from diverse backgrounds.”

One shining example of success Is the celebrated Dr. Marian Cloak, who was honored with an “Inventor Card” as part of the USPTO’s collectible card series. Dr. Croak emphasized the need for support and role models, explaining that “I think the more role models that people have, the more inspired they are to understand that they are capable of doing anything.” Dr. Croak will join Director Iancu later in October in the USPTO Speaker Series to address her path to success, her pioneering of VoIP advancements and 200 patents, and the goals of Direcor Iancu’s goals for a more diverse innovation pool.

However, these goals cannot be achieved by the USPTO or even the federal government alone. In the NCEAI are 29 industry representatives similarly committed to the cause, but industry support must be expanded for this to be successful.

Maier & Maier has long been a supporter of diverse inventorship in the industry, with a strong commitment to underserved inventors. Maier & Maier has made it a firm priority to assist solo inventors whenever possible and has a demonstrated commitment to leveling the playing field for inventors and practitioners alike. Our team consists of a diverse group of individuals speaking a variety of languages and from a variety of different countries, backgrounds, and identities.

We are committed to continuing on this path, and we welcome underrepresented inventors and practitioners to reach out to us at any time.


USPTO Announces Final Fee Schedule Update

The USPTO is set to implement changes to its Fee Schedule on October 2, 2020. Per the USPTO announcement, this update is “necessary to adjust to increasing costs and to provide necessary resources for Patent operations, including implementing the USPTO 2018-2022 Strategic Plan.”  The changes include an approximate 5% increase of fees across the board.

Certain fees were increased by substantial more than 5%. Most significant were AIA request and post-institution fees which were increased by up to 50%, with most coming in at 20-25% increases. This substantially affects the costs for PTAB post grant practice for petitioners and those considering their options for IP disputes.

This process began in 2017 in accordance with federal fee setting requirements. The process has included a public forum at the USPTO headquarters in Alexandria, Virginia, comments, and extensive review by the Patent Public Advisory Committee (PPAC). The fees were initially planned to be announced and come into effect earlier this summer but were delayed due to the state of the U.S. economy and the ongoing pandemic.

Notable changes include the addition of two new fees (for pro hac vice admission and effective January 1, 2021 a fee for non docx format submissions), four discontinued fees, and increases to most existing fees.

Further, it is especially important to note the following fee increases for PTAB proceedings:

  • Inter Partes Review Request Fee: This fee will increase from $15,000 to $19,000.
  • Inter Partes Review Post-Institution Fee: This fee will increase from $15,000 to $22,500
  • Total Fees for an instituted IPR increase from $30,000 to $41,500
  • Post Grant Review Request Fee: This fee will increase from $16,000 to $20,000
  • Post Grant Review Post-Institution Fee: This fee will increase from $22,000 to $27,500
  • Total Fees for an instituted PGR increase from $38,000 to $47,500
  • Additional fees may be incurred for each claim in excess of 20.

The full fee schedule table is available for download here and the USPTO announcement is available here.  In the meantime, filing cases before the October 2nd increase could provide significant cost savings and should be considered.